AMELIO GILBERT F 4
4 · GALECTIN THERAPEUTICS INC · Filed Jan 23, 2019
Insider Transaction Report
Form 4
AMELIO GILBERT F
Director
Transactions
- Exercise/Conversion
Common Stock
2019-01-21$0.89/sh+41,500$36,935→ 161,461 total - Tax Payment
Common Stock
2019-01-21$4.75/sh−7,776$36,936→ 153,685 total - Exercise/Conversion
Stock option (right to buy)
2019-01-21−41,500→ 0 totalExercise: $0.89Exp: 2026-12-15→ Common Stock (41,500 underlying) - Exercise/Conversion
Stock option (right to buy)
2019-01-21−62,250→ 0 totalExercise: $2.39Exp: 2027-12-14→ Common Stock (62,250 underlying) - Exercise/Conversion
Common Stock
2019-01-21$2.39/sh+62,250$148,778→ 215,935 total - Tax Payment
Common Stock
2019-01-21$4.75/sh−31,322$148,780→ 184,614 total
Footnotes (2)
- [F1]The options vested 100% on December 14, 2017.
- [F2]The options vested 100% on December 14, 2018.